课题基金 / 基金详情

Design and study of artificial nucleases for DNA photocleavage

Design and study of artificial nucleases for DNA photocleavage
DNA光裂解人工核酸酶的设计与研究
批准号:
341612-2007
负责人:
McFarland, Sherri
金额:
$1.81万
依托单位:
依托单位国家:
加拿大
项目类别:
Discovery Grants Program - Individual
财政年份:
2007
资助国家:
加拿大
项目状态:
已结题
起止时间:
2007-01-01 至 2008-12-31

项目摘要

项目成果

McFarland, Sherri的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Artificial nucleases are molecules capable of inducing single- or double-strand breaks in the DNA backbone.  Molecules that cleave DNA  upon activation with light are especially important in photodynamic therapy (PDT), a strategy that has been applied to the successful treatment of certain cancers and age-related macular degeneration.  Current clinical agents for PDT suffer from three major limitations:  (i) requirement for oxygen to function, (ii) minimum absorption of light at wavelengths most transparent to tissue, and (iii) inability to produce double-strand breaks.  This proposal outlines a research plan that is devoted to overcoming such limitations by introducing new  agents that elicit double-strand breaks in DNA under hypoxic conditions when activated with 700-900 nm light.  The first proposed family of DNA photocleavers is based on dinuclear Ru(II) complexes that absorb light >700 nm.  Extension of this family will include incorporation of Rh(II) to make hybrid multimetallic systems that cleave DNA in the absence of oxygen.  The multimetallic framework will provide two sites of reactivity for DNA cleavage.  Dual reactivity within 15-16 base pairs will introduce double-strand breaks which are more difficult for the cellular machinery to repair.       A related research stream involves  the jadomycins, a family of secondary metabolites that induces DNA strand scissions in the presence of Cu(II) or with light activation.  While  they fall short of the properties outlined for the ideal PDT agent, jadomycins exhibit cytotoxic activity against both Gram positive and Gram negative bacteria as well as some drug-resistant cancer cell lines. This research program will determine whether direct DNA cleavage contributes to the overall cytotoxicity of the jadomycins at intracellular Cu(II) concentrations.  In addition, the DNA photocleaving properties of the jadomycins will be investigated, with particular attention on the mechanism that predominates with Cu(II) activation versus light activation.  The role that L-digitoxose, a structural feature of jadomycin B, plays in DNA cleavage will also be probed to better understand how glycone incorporation aids in DNA recognition.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Investigation of Metal-Organic Hybrids as Photosensitizers for Bioinorganic Applications
  • 批准号:
    RGPIN-2015-04364
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $3.24万
  • 财政年份:
    2018
  • 负责人:
    McFarland, Sherri
  • 依托单位:
Investigation of Metal-Organic Hybrids as Photosensitizers for Bioinorganic Applications
  • 批准号:
    RGPIN-2015-04364
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $3.28万
  • 财政年份:
    2017
  • 负责人:
    McFarland, Sherri
  • 依托单位:
Investigation of Metal-Organic Hybrids as Photosensitizers for Bioinorganic Applications
  • 批准号:
    RGPIN-2015-04364
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $3.28万
  • 财政年份:
    2016
  • 负责人:
    McFarland, Sherri
  • 依托单位:
Investigation of Metal-Organic Hybrids as Photosensitizers for Bioinorganic Applications
  • 批准号:
    RGPIN-2015-04364
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $3.28万
  • 财政年份:
    2015
  • 负责人:
    McFarland, Sherri
  • 依托单位:
国内基金
海外基金
Incentive and governance schenism study of corporate green washing behavior in China: Based on an integiated view of econfiguration of environmental authority and decoupling logic
  • 批准号:
    --
  • 项目类别:
    外国学者研究基金项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    YU BYUNGJUN
  • 依托单位:
糖尿病ED中成纤维细胞衰老调控内皮细胞线粒体稳态失衡的机制研究
  • 批准号:
    82371634
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    赵福军
  • 依托单位:
酶响应的中性粒细胞外泌体载药体系在眼眶骨缺损修复中的作用及机制研究
  • 批准号:
    82371102
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    苏蕴
  • 依托单位:
CBP/p300-HADH轴在基础胰岛素分泌调节中的作用和机制研究
  • 批准号:
    82370798
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    王晓
  • 依托单位: